º£½ÇÆÆ½â°æ

´¡²µ²µ°ù±ð°Â±ð±ô±ôâ„¢400

Microwell culture plates for easy and reproducible production of embryoid bodies and spheroids

´¡²µ²µ°ù±ð°Â±ð±ô±ôâ„¢400

Microwell culture plates for easy and reproducible production of embryoid bodies and spheroids

Catalog #
(Select a product)
Microwell culture plates for easy and reproducible production of embryoid bodies and spheroids
Request Pricing Request Pricing

What's Included

  • ´¡²µ²µ°ù±ð°Â±ð±ô±ôâ„¢400 24-well plate
    • 1 Unit (Catalog #34411)
    • 5 Units (Catalog #34415)
  • ´¡²µ²µ°ù±ð°Â±ð±ô±ôâ„¢400 6-well plate
    • 1 Unit (Catalog #34421)
    • 5 Units (Catalog #34425)
  • ´¡²µ²µ°ù±ð°Â±ð±ô±ôâ„¢400 24-well Plate Starter Kit (Catalog #34450)
    • 2 x 24-well plates
    • 1 x Bottle of Anti-Adherence Rinsing Solution (Catalog #07010)
  • ´¡²µ²µ°ù±ð°Â±ð±ô±ôâ„¢400 6-well Plate Starter Kit (Catalog #34460)
    • 2 x 6-well plates
    • 1 x Bottle of Anti-Adherence Rinsing Solution (Catalog #07010)

Overview

AggreWellâ„¢ plates bring an easy, standardized approach to the generation of cell aggregates, including embryoid bodies (EBs) and spheroids. EBs and spheroids generated using AggreWellâ„¢ plates are consistent in size and shape, and are uniform within and between experiments.  New and improved second-generation AggreWellâ„¢ plates are compatible with a variety of cell types, including ES and iPS cells, cancer cells and more. Enhanced optical characteristics provide crystal clear imaging. Note: AggreWellâ„¢ Rinsing Solution is required for optimal EB and spheroid formation.

For guidance on choosing an AggreWellâ„¢ product including AggreWellâ„¢ 400, AggreWellâ„¢ 800, and AggreWellâ„¢ HT, please refer to this Tech Tip. Learn more about how to use how to use AggreWellâ„¢ or contact us for more information.
Subtype
Dishes and Plates
Species
Human, Mouse, Non-Human Primate, Other, Rat
Application
Differentiation, Spheroid Culture, Toxicity Assay
Brand
AggreWell

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
34450
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34415
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34415
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34411
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34411
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34421
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34421
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34460
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34425
Lot #
All
Language
English
Document Type
Product Name
Catalog #
34425
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Publications (28)

Unconventional auricular reconstruction using controlled scaffold buckling and chondrogenic cocktail containing muscle-derived cells. N. Huang et al. Bioactive materials 2026 Nov

Abstract

Tissue engineered auricles face challenges such as subpar graft mechanical robustness, insufficient stem/progenitor cells, and unidentified factors that specifically promote elastic cartilage. To tackle these, we developed resilient and bioactive 3D-printed scaffolds using two unconventional concepts, including controlled buckling compliant lattices for mechanical resilience and muscle-derived stem/progenitor cells (MDSCs) with defined biochemical factors for facile elastic cartilage-like regeneration. Our functionally graded design reduced stress by 63.1% relative to other graded designs, which was validated by finite element analysis and high-magnitude compressive testing. Notably, 91.7% of scaffolds remained undamaged in stark contrast to 100% failure for clinically-used MEDPOR® and 76.5% failure for other graded scaffolds. Further, we developed an elastic auricular regenerative cocktail (EARc) comprised of abundantly available MDSCs and elastic cartilage-specific biochemical factors. In vitro, mouse, and rabbit studies confirmed that EARc scaffolds facilitated mechanical resilience and elastic cartilage-like regeneration. In conclusion, EARc scaffolds demonstrate the unconventional application of buckling and muscle sourcing to enhance mechanical resilience and elastic-like cartilage-specific regeneration for auricular reconstruction.
CRISPR-engineered human lung organoids with a biomolecular condensate reporter enable mechanistic toxicity monitoring S-Y. Kim et al. Materials Today Bio 2026 Feb

Abstract

Understanding how chemical stress perturbs human lung physiology requires models that capture dynamic molecular responses in real time. Here, we established a CRISPR/Cas9-engineered human induced pluripotent stem cell (hiPSC)-derived lung organoid expressing endogenous G3BP1–mCherry, enabling live, non-destructive visualization of stress granule (SG) formation under toxicant exposure. The organoids recapitulated airway and alveolar epithelial diversity and displayed lamellar body-like ultrastructures, indicating advanced maturation. Time-lapse imaging revealed rapid and reversible SG dynamics across chemically distinct stressors, while cytotoxicity assays showed that these organoids are significantly more sensitive than conventional 2D or cancer-derived lung models. Importantly, SG dynamics were linked to exposure duration–dependent changes in epithelial barrier integrity, indicating that SG formation precedes overt epithelial injury and serves as an early indicator of toxicant-induced cellular stress. Integration with high-content screening enabled quantitative, image-based analysis of cellular stress phenotypes, greatly enhancing throughput and mechanistic insight, thereby provided next-generation New Approach Methodologies for lung toxicity assessment. Together, this hiPSC-derived lung organoid SG reporter platform links early molecular stress adaptation to tissue-level responses, offering a predictive and mechanistically informative framework for human-relevant lung toxicity evaluation.
Human pancreatic α-cell heterogeneity and trajectory inference analyses reveal SMOC1 as a β-cell dedifferentiation gene R. B. Kang et al. Nature Communications 2025 Oct

Abstract

β-cell dysfunction and dedifferentiation towards an α-cell-like phenotype are hallmarks of type 2 diabetes. However, the cell subtypes involved in β-to-α-cell transition are unknown. Using single-cell and single-nucleus RNA-seq, RNA velocity, PAGA/cell trajectory inference, and gene commonality, we interrogated α-β-cell fate switching in human islets. We found five α-cell subclusters with distinct transcriptomes. PAGA analysis showed bifurcating cell trajectories in non-diabetic while unidirectional cell trajectories from β-to-α-cells in type 2 diabetes islets suggesting dedifferentiation towards α-cells. Ten genes comprised the common signature genes in trajectories towards α-cells. Among these, the α-cell gene SMOC1 was expressed in β-cells in type 2 diabetes. Enhanced SMOC1 expression in β-cells decreased insulin expression and secretion and increased β-cell dedifferentiation markers. Collectively, these studies reveal differences in α-β-cell trajectories in non-diabetes and type 2 diabetes human islets, identify signature genes for β-to-α-cell trajectories, and discover SMOC1 as an inducer of β-cell dysfunction and dedifferentiation. Subject terms: Cell signalling, Diabetes, Differentiation